Altogen Biosystems Competitors and Similar CompaniesClear all
Altogen Biosystems's competitors and similar companies include Assembly Biosciences, Inotiv, Corcept Therapeutics and Vanda Pharmaceuticals.
 Altogen Biosystems Altogen Biosystems is a biotechnology company that develops and manufactures transfection kits for life sciences research, drug discovery, and development. |  Assembly Biosciences Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics. |  Inotiv Inotiv (formerly known as BioAnalytical Systems) is a company that provides research services to pharmaceutical and biotechnology companies. |  Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. |  Vanda Pharmaceuticals Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2008 | Founding Date 2005 | Founding Date 1974 | Founding Date 1998 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Las Vegas, US HQ | Locations South San Francisco, US HQ | Locations West Lafayette, US HQ | Locations Redwood City, US HQ | Locations Washington, US HQ Berlin, DE London, GB |
Employees | Employees 1 | Employees 11521% increase | Employees 1,945 | Employees 50042% increase | Employees 2845% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 112.4 m | Valuation ($) 47.3 m | Valuation ($) 5 b | Valuation ($) 273.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $72.3m (FY, 2025) | Revenue (est.) $513m (FY, 2025) | Revenue (est.) $761.4m (FY, 2025) | Revenue (est.) $216.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $392m (FY, 2025) | Cost of goods $13m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $121m (FY, 2025) | Gross profit $748.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($6.1m) (FY, 2025) | Net income ($68.6m) (FY, 2025) | Net income $99.7m (FY, 2025) | Net income ($220.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 359.4m | Total funding raised $ 80.1m | Total funding raised $ 54m |
For sources of this data, please see the company profile
View Company Profiles
Assembly Biosciences
HQ
South San Francisco, US
Employees
115↑ 21% increase
Assembly Biosciences is a clinical stage biotechnology company which develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.
View companyInotiv
HQ
West Lafayette, US
Employees
1,945
Inotiv (formerly known as BioAnalytical Systems) is a company that provides research services to pharmaceutical and biotechnology companies.
View companyCorcept Therapeutics
HQ
Redwood City, US
Employees
500↑ 42% increase
Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.
View companyVanda Pharmaceuticals
HQ
Washington, US
Employees
284↑ 5% increase
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
View company